Steve Duffy

Most Recent Articles by Steve Duffy

Urinary Incontinence Drug May Reduce Frequency of Hot Flashes

Urinary Incontinence Drug May Reduce Frequency of Hot Flashes

By

Oxybutynin, an anticholinergic used to treat urinary incontinence, may provide breast cancer survivors with an alternative treatment option for hot flashes, according to new research.

Novel <i>H. pylori</i> Eradication Therapy Effective in Phase 3 Trial

Novel H. pylori Eradication Therapy Effective in Phase 3 Trial

By

The ERADICATE Hp2 trial enrolled 455 dyspepsia patients at 55 sites across the US and randomized them to receive 4 capsules, 3 times daily, of either Talicia or the active comparator (amoxicillin 250mg and omeprazole 10mg), for a period of 14 days.

Novel NASH Treatment Gets FDA's Fast Track Designation

Novel NASH Treatment Gets FDA's Fast Track Designation

By

The Company has completed a first in human study in healthy volunteers; a Phase 2 trial in adults with NASH is due to begin soon in the US.

New Antibiotic Shows Promise as Potential Treatment for Uncomplicated Gonorrhea

New Antibiotic Shows Promise as Potential Treatment for Uncomplicated Gonorrhea

By

Unlike other antibiotics used to treat gonorrhea, zoliflodacin, a spiropyrimidinetrione antimicrobial agent, works by inhibiting DNA biosynthesis by arresting the cleaved covalent gyrase complex, thereby impeding bacterial growth.

FDA Amends Food Additive Regulations to No Longer Allow Use of 7 Substances

FDA Amends Food Additive Regulations to No Longer Allow Use of 7 Substances

By

The petition was submitted by a number of non-profit organizations including the Center for Science in the Public Interest and the Breast Cancer Fund.

More Articles by Steve Duffy

Sign Up for Free e-newsletters